EpCAM single-domain antibody D7
A single-domain antibody, anti-tumor drug technology, applied in the field of molecular biology, can solve the problems of unsatisfactory results of clinical trials of immune-directed therapy, and achieve the effect of improving specific binding performance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0056] 1. Construction of EpCAM single-domain antibody library
[0057] (1) Purchasing commercially available EpCAM recombinant proteins (ORIGENE Company) Here, other commercially available EpCAM recombinant proteins can be used, and the way to purchase EpCAM recombinant proteins will not affect the realization of the purpose of subsequent experiments. According to the instructions, the purchased recombinant protein was taken out, mixed with an equal volume of Freund's incomplete adjuvant and fully emulsified, and used as a vaccine to immunize alpacas.
[0058] (2) Using the method of subcutaneous multi-point injection, immunize two adult male alpacas for 5 consecutive immunizations, with a one-week interval between each time, to promote the production of EpCAM antigen-specific single-domain antibodies;
[0059] (3) After 5 times of immunization, according to the detection titer (take 5ml of blood from the common carotid artery before each immunization, collect the upper serum...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com